The study seeks to investigate the neurological effects caused by Covid-19 in childrenand adolescents in the 6-16 age group. To do this, neuropsychological scales, an EEG andan MRI were used.
Not Provided
Diagnostic Test: Psychological tests, EEG, Magnetic Resonance
Patients are administered some psychological tests, if they are positive they move on to
the next stage, otherwise the patients leave the practice. If they are positive, EEG, MRI
and other psychological tests are also administered.
Inclusion Criteria:
- Age between 6 years and 16 years and 11 months
- Symptomatology compatible with long neurological COVID, specifically: persistence or
appearance of new neurological signs/symptoms (e.g. fatigue, headache, sleep
disturbance, cognitive dysfunction, memory difficulties, emotional or mood
disorders, vertigo cognitive dysfunction, memory difficulties, emotional or mood
disorders, dizziness, dysautonomia, movement disorders movement disorders, ataxia,
tremor, epilepsy, muscle weakness, myalgia, hyposmia, hypogeusia hearing loss or
tinnitus and/or sensorimotor deficits such as hypoesthesia, dysesthesia) after three
months after established SARS-CoV-2 infection, as well as persistence of these
symptoms for at least two months, in the absence of a clear aetiology.
- Signature of the appropriate Informed Consent by caregiver(s) and patient(s)
Exclusion Criteria:
- Poor knowledge of the Italian language or other limitation of verbal communication
that compromises the subject's ability to perform neuropsychological tests
- Need for sedation to perform brain MRI 7 Tesla
- Neurological or neuropsychiatric disorder diagnosed prior to COVID-19 diagnosis
- Caregiver's failure to sign consent
Azienda Ospedaliera Universitaria Pisana
Pisa, PI, Italy
Investigator: Vanessa Scacciati, Borsista
Contact: 3349349570
vanessa.scacciati@ao-pisa.toscana.it
Alessandro Orsini, Dirigente medico
+050 995995
neuropediatriapisa@gmail.com
Not Provided